Follows people with type 1 diabetes after islet transplant graft loss
Observes adults with type 1 diabetes whose islet transplant graft was lost.
Key facts
- Who runs it
- Rodolfo Alejandro
- Where
- Miami, United StatesSee the site
- Trial code
- Registry title
- Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- Dec 2008
- Expected to end
- Jul 2028
- Type of study
- Observational
- Record updated
- 23 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with type 1 diabetes who have had an islet-alone transplant and whose transplanted islet cells have stopped working. They are followed over a long time.
- Age
- 18 Years to 75 Years
- Sex
- All sexes can join.
- Disease stage
- Type 1 diabetes with islet graft loss after an islet transplant.
- Earlier treatment
- Must have had at least one islet-alone transplant (an islet transplant without any other organ transplant).
Main reasons for not taking part
- Cannot give written informed consent
- Mentally unstable or unable to follow the study procedures
- History of any solid organ transplant
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- History of at least one islet alone transplant (ie islet transplant in the absence of any other organ transplant)
Who cannot take part
- History of any solid organ transplant
- Inability to provide written informed consent
- Mentally unstable and/or unable to comply with the procedures of the study protocol
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where in United States
- Diabetes Research InstituteMiami, United StatesContact: Rodolfo Alejandro, MDTaking people
About the trial
What the trial wants to find out
This is a single-center, prospective, open label study in islet transplant recipients following islet graft loss.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss
- Plain-language title
- Follows people with type 1 diabetes after islet transplant graft lossGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT02000687, who can take part
- Publications
- Long-term Persistence of Allosensitization After Islet Allograft Failure.Transplantation, 2021
- Record updated
- 23 March 2026